The city on Wednesday will officially launch what it is calling a “neighborhood wellness court” in Kensington, an initiative ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Like many physicians, my career was initially driven by my quest to become a healer, although I must admit, I really did not ...

When children with obesity undergo weight-loss treatment, the results have effects later in life, and the risk of serious health problems and premature death is lower as they reach young adulthood.

The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...

Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to the pharmaceutical company. The nasal spray can be given to people who haven’t seen improvements ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

On Friday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc’s (NASDAQ:AZN) Datroway (datopotamab ...

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...